Hypersensitivity reactions with proton pump inhibitors: five years of clinical experience
Allergologia et Immunopathologia · 01.03.2026 · 54 (2) · 70-75
DOI: 10.15586/aei.v54i2.1537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, online erschienen am 01.03.2026. Verfasst von Melis Yağdıran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Diseases, Division of Immunology and Allergy, Atatürk Sanatoryum Training and Research Hospital, University of Health Sciences, A…. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Drug Hypersensitivity. Gefördert von: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors..
Abstract (Originalsprache)
Introduction
Proton pump inhibitors (PPIs) are generally well tolerated and are frequently prescribed drugs because their risk of adverse effects is 1–3%. Although PPIs have a good safety profile, allergic reactions to these molecules can occur. We aimed to investigate hypersensitivity reactions in patients who underwent oral provocation tests with PPIs in our clinic.
Methods
In all, 58 subjects who applied to allergy clinic between January 2018 and December 2023 with a history of early allergic reactions with PPIs and subsequently underwent oral provocation testing to find a diagnostic or safe alternative PPI were included in our study. Information on the subjects’ demographic and clinical data and the results of provocation tests was recorded by reviewing patient records.
Results
Of the 58 subjects included in the study, 44 (75.9%) were females. The mean age of the patients was 54.4 ± 13.8 years. Fifty-three (91.4%) subjects had a history of allergic reactions to a single PPI and 5 (8.6%) subjects had a history of allergic reactions to two different PPIs, such as lansoprazole, pantoprazole, rabeprazole, esomeprazole, and omeprazole. Intradermal skin testing was performed in 51 (87.9%) of the subjects and all were found to be negative. After the provocation test, only two patients (3.4%) developed early-onset hypersensitivity reactions, one with lansoprazole and the other with esomeprazole.
Conclusion
Skin testing is a valuable tool in predicting hypersensitivity reactions associated with PPIs. Although rare, hypersensitivity reactions may occur in patients with negative skin tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chest Diseases, Division of Immunology and Allergy, Atatürk Sanatoryum Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
- Department of Chest Diseases, Division of Immunology and Allergy, Atatürk Sanatoryum Training and Research Hospital, University of Health Sciences, Ankara, Turkey; kurtulus.aksu@sbu.edu.tr.
Förderung
- This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Zitieren
APA
Yağdıran, M., Aksu, K., Akkale, Ö., Tuğlu, H. Ç., Telli, O., Çelik, F. D., & Solak, G. T. V. (2026). Hypersensitivity reactions with proton pump inhibitors: five years of clinical experience. Allergologia et Immunopathologia, 54(2), 70-75. https://doi.org/10.15586/aei.v54i2.1537
Vancouver
Yağdıran M, Aksu K, Akkale Ö, Tuğlu HÇ, Telli O, Çelik FD, et al. Hypersensitivity reactions with proton pump inhibitors: five years of clinical experience. Allergologia et Immunopathologia. 2026;54(2):70-75. doi:10.15586/aei.v54i2.1537
BibTeX
@article{Yadran2026,
author = {Yağdıran, Melis and Aksu, Kurtuluş and Akkale, Özgür and Tuğlu, Hatice Çelik and Telli, Onur and Çelik, Fatma Dindar and Solak, Gürgün Tuğçe Vural},
title = {Hypersensitivity reactions with proton pump inhibitors: five years of clinical experience},
journal = {Allergologia et Immunopathologia},
year = {2026},
volume = {54},
number = {2},
pages = {70--75},
doi = {10.15586/aei.v54i2.1537}
}
EUVIMED